Red wine
polyphenols (RWPs) have been reported to exert beneficial effects in preventing
cardiovascular diseases, such as
hypertension. We studied the effects of chronic treatment with RWPs and
apocynin, an inhibitor of the
nicotinamide adenine dinucleotide phosphate (
NADPH) oxidase, on blood pressure, endothelial function, and oxidative status in
deoxycorticosterone acetate (
DOCA)-
salt-induced
hypertension. Rats were administered RWPs (40 mg/kg) or
apocynin (33 microg/kg) daily by gavage for 5 weeks. Plasma
catechin levels were detected only after RWP treatment. RWPs and
apocynin prevented both the increase in systolic blood pressure and the
proteinuria induced by
DOCA-
salt. Plasma
malonyldialdehyde levels, urinary iso-
prostaglandin F(2alpha) excretion, aortic
superoxide production, and aortic
NADPH oxidase activity were found to be increased in animals of the
DOCA group. RWP and
apocynin treatments reduced these parameters in
DOCA-
salt rats, having no effect on control rats. However, only RWPs reduced the increase in plasma
endothelin-1 (ET-1) levels and aortic p22(
phox) gene overexpression found in
DOCA-
salt animals. RWPs and
apocynin also improved the blunted endothelium-dependent relaxation response to
acetylcholine in
noradrenaline-precontracted aortic rings. All these results suggest that chronic treatment with RWPs prevents
hypertension and vascular dysfunction. RWPs prevent vascular oxidative stress by inhibiting
NADPH oxidase activity and/or by reducing ET-1 release.